Drugs / Reference1505
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02534896 | Nov 2015 → Mar 2018 | rheumatoid arthritis | Sun Pharmaceutical Industries, Inc. | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Reference1505 | “Reference1505 and Placebo” NCT02534896 ↗ |